Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 10, pp 1026-1034, issn 1073-449X, 9 p.Article

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article

A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patientsREAD, Charles H; TANSEY, Michael J; MENDA, Yusuf et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 9, pp 4229-4233, issn 0021-972X, 5 p.Article

A patient with myelodyplastic syndrome, pulmonary nodules, and worsening infiltratesWOHLRAB, Juliette L; ANDERSON, Eric D; READ, Charles A et al.Chest. 2001, Vol 120, Num 3, pp 1014-1017, issn 0012-3692Article